Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is overpriced and in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Bajaj Healthcare Ltd manufactures active pharmaceutical ingredients and formulations, focusing on amino acids and nutritional supplements for healthcare industries.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 1.31%
Bajaj Healthcare Limited has informed the Exchange regarding 'Machine Readable Form / Legible copy of Financial Results for the half-year ended 30th September, 2024'. | Download
Bajaj Healthcare Limited has informed the Exchange regarding 'Machine Readable Form / Legible copy of Financial Results for the half-year ended 30th September, 2024'. | Download
Final • Div/Share: ₹ 1
Decreased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 8.55%